Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer With CA125 Elevation From Complete Response After Therapy
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
A prospective cohort imaging study in a single institution to evaluate 68Ga- FAPI-46 and 18F-FDG PET/CT imaging for detecting recurrent tumor lesions in patients of ovarian cancer with CA125 elevation from complete response after therapy
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 30
Maximum Age: 80
Healthy Volunteers: f
View:
• Pathologically proven ovarian cancer with complete response after therapy
• Age between 30 and 80
• Elevation of serum CA125 value above the normal range (\>35 U/mL) or doubling of serum CA125 value within the normal range
• ECOG performance status grade 0 or 1 and willing to receive further therapy if disease recurrence is confirmed
• Willing to enter this prospective study with signed informed consent form
Locations
Other Locations
Taiwan
Chang-Gung Memorial Hospital, Linkou Branch
RECRUITING
Taoyuan
Contact Information
Primary
Feng-Yuan Liu
billliu@cgmh.org.tw
0975365782
Time Frame
Start Date: 2022-08-01
Estimated Completion Date: 2028-07-31
Participants
Target number of participants: 45
Treatments
Experimental: 68Ga-FAPI ,PET/CT
Inject 68Ga-FAPI and then perform PET/CT scan.
Related Therapeutic Areas
Sponsors
Leads: Chang Gung Memorial Hospital